WuXi Biologics (Cayman) (FRA:1FW2) Price-to-Tangible-Book : 1.52 (As of Apr. 28, 2024)

View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) Price-to-Tangible-Book?

As of today (2024-04-28), WuXi Biologics (Cayman)'s share price is €1.6402. WuXi Biologics (Cayman)'s Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was €1.08. Hence, WuXi Biologics (Cayman)'s Price to Tangible Book Ratio of today is 1.52.

The historical rank and industry rank for WuXi Biologics (Cayman)'s Price-to-Tangible-Book or its related term are showing as below:

FRA:1FW2' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.37 Med: 9.42 Max: 17.59
Current: 1.37

During the past 10 years, WuXi Biologics (Cayman)'s highest Price to Tangible Book Ratio was 17.59. The lowest was 1.37. And the median was 9.42.

FRA:1FW2's Price-to-Tangible-Book is ranked better than
74.92% of 1220 companies
in the Biotechnology industry
Industry Median: 2.65 vs FRA:1FW2: 1.37

A closely related ratio is called PB Ratio. As of today, WuXi Biologics (Cayman)'s share price is €1.6402. WuXi Biologics (Cayman)'s Book Value per Sharefor the quarter that ended in Jun. 2023 was €1.15. Hence, WuXi Biologics (Cayman)'s P/B Ratio of today is 1.43.

WuXi Biologics (Cayman) Price-to-Tangible-Book Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Price-to-Tangible-Book Chart

WuXi Biologics (Cayman) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

9.35

17.32

10.11

6.81

2.91

WuXi Biologics (Cayman) Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial													10.11	8.03	6.81	4.04	2.91

Competitive Comparison of WuXi Biologics (Cayman)'s Price-to-Tangible-Book

For the Biotechnology subindustry, WuXi Biologics (Cayman)'s Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi Biologics (Cayman)'s Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WuXi Biologics (Cayman)'s Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where WuXi Biologics (Cayman)'s Price-to-Tangible-Book falls into.

WuXi Biologics (Cayman) Price-to-Tangible-Book Calculation

WuXi Biologics (Cayman)'s price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	1.6402	/	1.082
	=	1.52

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

WuXi Biologics (Cayman) Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi Biologics (Cayman) (FRA:1FW2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (FRA:1FW2) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

WXIBF:USA WXXWY:USA 2269:Mexico 02269:Hong Kong 1FW1:Germany

Address

No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092

Website

https://www.wuxibiologics.com

WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.

WuXi Biologics (Cayman) (FRA:1FW2) Headlines

No Headlines